Bottom line
What is LEQIX's expense ratio?
LEQIX's expense ratio is 2.35%, or about $235 a year on every $10,000 invested. That is more expensive than 96% of large blend funds we track (median 0.83%). It has no front-end sales load.
Updated Apr 29, 2026
LEQIX fee table
| Net expense ratio | 2.35% |
|---|---|
| Gross expense ratio | 2.67% |
| Management fee | 1.5% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 1.17% |
| Fee waiver / reimbursement | -0.32% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Apr 29, 2026
What LEQIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| LEQIX | $238 | $799 | $1,387 | $2,979 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.35% expense ratio costs roughly $115,900 in lost growth, versus about $46,700 for the median large blend fund (0.83%).